Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 1 26Phase 3 5Phase 1/2 5Phase NA 3Phase 4 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 153INDUSTRY 76OTHER_GOV 11NIH 5NETWORK 2UNKNOWN 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 81Carcinoma, Non-Small-Cell Lung 41Colonic Neoplasms 40Lung Neoplasms 39Leukemia 36Rectal Neoplasms 34Lymphoma 34Colorectal Neoplasms 33Prostatic Neoplasms 24Multiple Myeloma 23Lymphoma, Follicular 22Leukemia, Myeloid, Acute 19Ovarian Neoplasms 18Lymphoma, Non-Hodgkin 18Leukemia, Lymphocytic, Chronic, B-Cell 18Lymphoma, Large B-Cell, Diffuse 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Melanoma 16Head and Neck Neoplasms 15Urinary Bladder Neoplasms 14Neoplasms, Plasma Cell 14Lymphoma, Large-Cell, Immunoblastic 14Burkitt Lymphoma 14Squamous Cell Carcinoma of Head and Neck 12Pancreatic Neoplasms 12Myelodysplastic Syndromes 12Leukemia, Myelomonocytic, Acute 12Leukemia, Monocytic, Acute 12Leukemia, Megakaryoblastic, Acute 12Leukemia, Erythroblastic, Acute 12

Interventions

Fluorouracil 2Cisplatin 2Tinidazole 1Radiotherapy 1Oxaliplatin 1Omeprazole 1Neoadjuvant Therapy 1Leucovorin 1Irinotecan 1Epirubicin 1Docetaxel 1Clarithromycin 1Chlorambucil 1Chemotherapy, Adjuvant 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × NIH × Stomach Neoplasms × Clear all
NCT00941655 2019-11-13

Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
15 enrolled 18 charts
Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms

NCT00002615 2013-12-19

Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

National Cancer Institute (NCI)

Phase 3 Completed
500 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00003617 2013-09-20

Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00978549 2013-08-07

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

National Cancer Institute (NCI)

Phase 3 Completed
320 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Nausea, Pain, Stomach Neoplasms, Vomiting

NCT00182611 2013-06-26

S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer

National Cancer Institute (NCI)

Phase 3 Completed
100 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡